Growth in IVD Testing Despite Economic Jitters, Says Report

Top Quote Market size, forecasts, and shares are provided; and discussion of regional numbers of each segment is provided where possible End Quote
  • (1888PressRelease) July 31, 2010 - has announced the addition of Kalorama Information's new report "Worldwide Market for In Vitro Diagnostic Tests, 7th Edition," to their collection of reports. For more information, visit:

    According to Kalorama the market has already weathered price declines and as a result developed innovative technologies and approaches. This has dulled the impact of a recession which has hurt other industries. Digital pathology, multiplex assays, automation and test service commercialization represent areas where the industry has developed new approaches. The market changes described in the report were on display at the American Association for Clinical Chemistry (AACC) convention in Anaheim, CA this week.

    "The convention reflected what we've said in the report; that despite economic hard times, the IVD industry is on an upswing," said Shara Rosen, senior diagnostic analyst for Kalorama Information and author of the study. "A number of world events bode well for the future of testing."

    Trends such as the use of biomarkers and molecular approaches to testing have only increased since the last edition of the report. Consolidation has been a factor in an industry that is dominated by Roche, Siemens, and Abbott. The report notes that 72 percent of the revenue in 2009 was earned by just 18 companies. This hasn't stopped scores of new companies with unique approaches from competing in diagnostics, according to Kalorama.

    The report, "Worldwide Market for In Vitro Diagnostic Tests, 7th Edition," has more information on segment market sizes, forecasts, company analyses, and test product development.

    Veronica Franco
    vfranco ( @ ) marketresearch dot com

  • FB Icon Twitter Icon In-Icon
Contact Information